Payment overview · 2025
General Payments
$255.49
2 reported records · 2 companies
Healthcare provider profile · identity verified
Sanjay Sharma, DO
Allopathic & Osteopathic Physicians|Family Medicine · ARNOLD, MO · NPI 1447359492
Verified facts
What the public records show
CMS Open Payments records show Sanjay Sharma, DO received $255.49 in general payments during 2025 across 2 reported records.
Amgen Inc. accounted for 54.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $139.16 | 54.5% | 1 | 2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $116.33 | 45.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $255.49 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| GLASSIA Normalized: glassia |
Biological | Takeda Pharmaceuticals U.S.A., Inc. | $116.33 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 940 | 214 |
| Amlodipine Besylate | Amlodipine Besylate | 596 | 101 |
| Levothyroxine Sodium | Levothyroxine Sodium | 567 | 104 |
| Omeprazole | Omeprazole | 499 | 118 |
| Lisinopril | Lisinopril | 453 | 98 |
| Tamsulosin Hcl | Tamsulosin Hcl | 307 | 61 |
| Donepezil Hcl | Donepezil Hcl | 300 | 30 |
| Eliquis | Apixaban | 298 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 292 | 54 |
| Furosemide | Furosemide | 273 | 53 |
| Trazodone Hcl | Trazodone Hcl | 267 | 55 |
| Losartan Potassium | Losartan Potassium | 249 | 57 |
| Escitalopram Oxalate | Escitalopram Oxalate | 246 | 35 |
| Gabapentin | Gabapentin | 245 | 70 |
| Prednisone | Prednisone | 245 | 144 |
| Metoprolol Tartrate | Metoprolol Tartrate | 232 | 68 |
| Memantine Hcl | Memantine Hcl | 231 | 16 |
| Pantoprazole Sodium | Pantoprazole Sodium | 225 | 34 |
| Alendronate Sodium | Alendronate Sodium | 205 | 38 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 205 | 52 |
| Potassium Chloride | Potassium Chloride | 196 | 42 |
| Mirtazapine | Mirtazapine | 187 | 27 |
| Buspirone Hcl | Buspirone Hcl | 178 | 33 |
| Sertraline Hcl | Sertraline Hcl | 172 | 33 |
| Famotidine | Famotidine | 157 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 156 | 26 |
| Finasteride | Finasteride | 156 | 32 |
| Metformin Hcl Er | Metformin Hcl | 156 | 47 |
| Simvastatin | Simvastatin | 137 | 36 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 137 | 42 |
| Duloxetine Hcl | Duloxetine Hcl | 134 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 134 | 37 |
| Allopurinol | Allopurinol | 129 | 29 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 127 | 37 |
| Glipizide Er | Glipizide | 122 | 36 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 117 | 27 |
| Montelukast Sodium | Montelukast Sodium | 116 | 24 |
| Metformin Hcl | Metformin Hcl | 113 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 101 | 35 |
| Pravastatin Sodium | Pravastatin Sodium | 101 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 100 | 18 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 95 | 32 |
| Tizanidine Hcl | Tizanidine Hcl | 94 | 43 |
| Clonazepam | Clonazepam | 91 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 91 | suppressed |
| Atenolol | Atenolol | 87 | 19 |
| Azithromycin | Azithromycin | 85 | 64 |
| Tramadol Hcl | Tramadol Hcl | 85 | 36 |
| Fluoxetine Hcl | Fluoxetine Hcl | 84 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 81 | 35 |
| Alprazolam | Alprazolam | 79 | 24 |
| Warfarin Sodium | Warfarin Sodium | 76 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 73 | 18 |
| Lovastatin | Lovastatin | 72 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 70 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 67 | 53 |
| Midodrine Hcl | Midodrine Hcl | 67 | suppressed |
| Spironolactone | Spironolactone | 66 | 15 |
| Carvedilol | Carvedilol | 65 | 17 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 65 | 54 |
| Zolpidem Tartrate | Zolpidem Tartrate | 63 | 11 |
| Digoxin | Digoxin | 59 | 16 |
| Meloxicam | Meloxicam | 56 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 56 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 53 | suppressed |
| Lorazepam | Lorazepam | 53 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | suppressed |
| Bupropion Xl | Bupropion Hcl | 49 | 14 |
| Loperamide | Loperamide Hcl | 49 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 49 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 49 | 25 |
| Torsemide | Torsemide | 48 | 17 |
| Xarelto | Rivaroxaban | 46 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 43 | 34 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 43 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 40 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 40 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 39 | suppressed |
| Chlorthalidone | Chlorthalidone | 38 | suppressed |
| Irbesartan | Irbesartan | 37 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 35 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 35 | 35 |
| Celecoxib | Celecoxib | 34 | suppressed |
| Glimepiride | Glimepiride | 34 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 34 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 33 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 32 | suppressed |
| Entresto | Sacubitril/Valsartan | 31 | suppressed |
| Folic Acid | Folic Acid | 31 | suppressed |
| Temazepam | Temazepam | 31 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 30 | 30 |
| Amoxicillin | Amoxicillin | 29 | 25 |
| Azelastine Hcl | Azelastine Hcl | 29 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 27 |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 28 | suppressed |
| Methotrexate | Methotrexate Sodium | 28 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 28 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 28 | suppressed |
| Valsartan | Valsartan | 28 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 26 | suppressed |
| Indapamide | Indapamide | 26 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 26 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 26 | suppressed |
| Verapamil Er | Verapamil Hcl | 26 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Latanoprost | Latanoprost | 24 | suppressed |
| Ozempic | Semaglutide | 24 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 24 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 23 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Levetiracetam | Levetiracetam | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 21 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 20 | suppressed |
| Ibuprofen | Ibuprofen | 19 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 18 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 18 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 18 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 18 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 17 | suppressed |
| Jardiance | Empagliflozin | 16 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | 13 |
| Topiramate | Topiramate | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Balsalazide Disodium | Balsalazide Disodium | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | 11 |
| Sotalol | Sotalol Hcl | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Cyclosporine | Cyclosporine | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 13 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 13 | suppressed |
| Benzonatate | Benzonatate | 12 | suppressed |
| Cartia Xt | Diltiazem Hcl | 12 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Pregabalin | Pregabalin | 12 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Baclofen | Baclofen | 11 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $255.49 · 2 records | Amgen Inc. | GLASSIA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error